- Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol 2017;216:110-120.e6 pdf
- Dragan I, Georgiou T, Prodan N, Akolekar R, Nicolaides KH. Screening for pre-eclampsia using sFlt-1/PlGF ratio cut-off of 38 at 30-37 weeks' gestation. Ultrasound Obstet Gynecol 2017;49:73-77 pdf
- Andrietti S, Carlucci S, Wright A, Wright D, Nicolaides KH. Repeat measurements of uterine artery pulsatility index, mean arterial pressure and serum placental growth factor at 12, 22 and 32 weeks in the prediction of preeclampsia. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17403 pdf
- Panaitescu AM, Wright D, Militello A, Akolekar R, Nicolaides KH. Proposed clinical management of pregnancies after combined screening for preeclampsia at 35-37 weeks' gestation. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17419 pdf
- Wright D, Dragan I, Syngelaki A, Akolekar R, Nicolaides KH. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 30-34 weeks' gestation. Ultrasound Obstet Gynecol 2017;49:194-200 pdf
- Litwinska M, Wright D, Efeturk T, Ceccacci I, Nicolaides KH. Proposed clinical management of pregnancies after combined screening for preeclampsia at 19-24 weeks' gestation. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17418 pdf
- O' Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, de Alvarado M, Carbone IF, Dutemeyer V, Fiolna M, Frick A, Karagiotis N, Mastrodima S, de Paco Matallana C, Papaioannou G, Pazos A, Plasencia W, Nicolaides KH. Multicenter screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison to NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17455 pdf
- Bahado-Singh RO, Syngelaki A, Mandal R, Graham SF, Akolekar R, Han B, Bjondahl TC, Dong E, Bauer S, Alpay-Savasan Z, Turkoglu O, Ogunyemi D, Poon LC, Wishart DS, Nicolaides KH. Metabolomic determination of pathogenesis of late-onset preeclampsia. J Matern Fetal Neonatal Med 2017;30:658-64 pdf
- Guy GP, Ling HZ, Garcia P, Poon LC, Nicolaides KH. Maternal cardiovascular function at 35-37 weeks' gestation: Relation to maternal characteristics. Ultrasound Obstet Gynecol 2017;49:39-45 pdf
- Guy GP, Ling HZ, Garcia P, Poon LC, Nicolaides KH. Maternal cardiac function at 35-37 weeks' gestation: prediction of pre-eclampsia and gestational hypertension. Ultrasound Obstet Gynecol 2017;49:61-66 pdf
- Panaitescu AM, Akolekar R, Kametas N, Syngelaki A, Nicolaides KH. Impaired placentation in women with chronic hypertension that develop preeclampsia. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17517 pdf
- Francisco C, Wright D, Benkő Z, Syngelaki A, Nicolaides KH. Hidden high rate of preeclampsia in twin compared to singleton pregnancies. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17470 pdf
- Guy GP, Ling HZ, Machuca M, Poon LC, Nicolaides KH. Effect of change in posture on maternal functional hemodynamics at 35-37 weeks' gestation. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17466 pdf
- Dragan I, Wright D, Fiolna M, Leipold G, Nicolaides KH. Development of preeclampsia within four weeks of sFLT to PLGF ratio >38: Comparison of performance at 31-34 versus 35-37 weeks' gestation. Ultrasound Obstet Gynecol 2017;49:209-12 pdf
- Francisco C, Wright D, Benkő Z, Syngelaki A, Nicolaides KH. Competing risks model in screening for preeclampsia in twin pregnancies by maternal characteristics and medical history. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17529 pdf
- Tan MY, Wright D, Koutoulas L, Akolekar R, Nicolaides KH. Comparison of screening for preeclampsia at 31-34 weeks' gestation by the sFLT to PLGF ratio and a method combining maternal factors with sFLT-1 and PLGF. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17307
- Tan MY, Wright D, Koutoulas L, Akolekar R, Nicolaides KH. Comparison of screening for pre-eclampsia at 31-34 weeks' gestation by sFlt-1/PlGF ratio and a method combining maternal factors with sFlt-1 and PlGF. Ultrasound Obstet Gynecol 2017;49:201-8 pdf
- Panaitescu AM, Syngelaki A, Prodan N, Akolekar R, Nicolaides KH. Chronic hypertension and adverse pregnancy outcomes: a cohort study. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17493 pdf
- Sammar M, Syngelaki A, Sharabi-Nov A, Nicolaides K, Meiri H. Can Staining of Damaged Proteins in Urine Effectively Predict Preeclampsia?. Fetal Diagn Ther 2017;41:23-31 pdf
- O'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, Wright A, Akolekar R, Cicero S, Janga D, Jani J, Molina FS, de Paco Matallana C, Papantoniou N, Persico N, Plasencia W, Singh M, Nicolaides KH. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17399 pdf